RedHill Biopharma Announces Planned Expansion of Opaganib Glob...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, NC, Feb. 23, 2021 /PRNewswire-AsiaNet / -- Following review of data from the U.S. Phase 2 study by the FDA, RedHill plans to expand the global Phase 2/3 study of orally-administered opaganib for severe COVID-19 to the U.S. The study has enrolled over 50% of the targeted 464 patients gl...
Authors: LATEST ASIANET NEWS RELEASES